Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
20-hydroxyeicosatetraenoic Acid (20-HETE)
100%
Cognitive Dementia
100%
Vascular Cognitive Impairment
100%
Alzheimer's Disease
80%
Alzheime's Disease
80%
Hypertension
60%
Cognitive Impairment
40%
Alzheimer's Disease Dementia
40%
Related Dementias
40%
Inflammation
20%
Neurodegeneration
20%
Clinical Trials
20%
Diabetes
20%
Cerebral Autoregulation
20%
Genome-wide Association Study
20%
Strong Correlation
20%
Epidemiology Study
20%
Therapeutic Target
20%
Therapeutic Agents
20%
Human Genome
20%
Disease Progression
20%
Complex Role
20%
CYP4A
20%
Genetic Variants
20%
Blood-brain Barrier Integrity
20%
Multiple Persons
20%
Alternative Therapeutics
20%
Human Population Studies
20%
Cytochrome P450 4A
20%
Multiple Drugs
20%
Brain Atrophy
20%
Vascular Contributions
20%
Cerebrovascular Risk Factors
20%
Alternative Evaluation
20%
Cardiovascular Risk Factors
20%
Vasoconstrictor
20%
Inciting Event
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Cognitive Defect
100%
20 Hydroxyicosatetraenoic Acid
100%
Hypertension
50%
Cerebrovascular Accident
33%
Cytochrome P450 4A
33%
Amyloid Protein
33%
Clinical Trial
16%
Inflammation
16%
Atherosclerosis
16%
Enzymes
16%
Population Study
16%
Nerve Degeneration
16%
Brain Atrophy
16%
Blood-Brain Barrier
16%
Diseases
16%
Epidemiology
16%
Pathogenesis
16%
Neuroscience
Cognitive Disorders
100%
Alzheimer's Disease
100%
20 Hydroxyicosatetraenoic Acid
100%
Hypertension
50%
Amyloid Protein
33%
Cytochrome P450 4A
33%
Cerebrovascular Accident
33%
Neurodegeneration
16%
Blood Brain Barrier
16%
Autoregulation
16%
Cardiovascular System
16%
Vasoconstrictors
16%
Genome-Wide Association Study
16%
Enzymes
16%
Risk Factor
16%
Genetics
16%